Drawing for ADAMANT HEALTH

USPTO serial 79353258

ADAMANT HEALTH

Reviewed by CopyMark Law Group

Reg. 7324473Status 700Registered
Filing date
Status date
Registration date
Mar 12, 2024
Examiner
O'BRIEN, JENNIFER LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ADAMANT HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kiranjit K Dharsan

Kiranjit K Dharsan Seiter IP1110 N Virgil Ave, Suite #98436Los Angeles, CA 90029United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software, particularly mobile applications, computer programs, and cloud software, used for measurements and analysis services for operating medical measuring apparatus, analyzing medical data, posting and uploading dataACTIVE—
010Medical measuring apparatus used to provide measurement and analysis services in the medical field, namely, medical apparatus for measuring and analysing muscle function and motionACTIVE—
042Measurement and analysis services for medical research use, namely, medical research in the nature of measuring and analysing muscle function and motionACTIVE—
044Medical measurement services for healthcare use, namely, medical analysis for the diagnosis and treatment of persons, medical analysis services for the diagnosis of persons of muscle function and motion; human health care services for providing measurement and analysis services; medical measurement and analysis services for the patient care, namely, medical analysis for the diagnosis and treatment of persons, medical analysis services for the diagnosis of persons of muscle function and motion; analysis services for healthcare use, namely, medical analysis services relating to the treatment of patientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 1, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 1, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 11, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 19, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 19, 2024FIMPFINAL DISPOSITION PROCESSED—
Jun 13, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 18, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 12, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 12, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 26, 2023GPNXNOTIFICATION PROCESSED BY IB—
Dec 26, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 26, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 6, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 6, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 6, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 17, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Nov 17, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 17, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 17, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 10, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 10, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 10, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 27, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 6, 2023RFNTREFUSAL PROCESSED BY IB—
May 12, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 12, 2023RFRRREFUSAL PROCESSED BY MPU—
Mar 26, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 25, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2023DOCKASSIGNED TO EXAMINER—
Nov 19, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 25, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 20, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance